Inhibition of apoptosis-regulated signaling kinase-1 and prevention of congestive heart failure by estrogen

M Satoh, CM Matter, H Ogita, K Takeshita, CY Wang… - Circulation, 2007 - Am Heart Assoc
Background—Epidemiological studies have shown gender differences in the incidence of
congestive heart failure (CHF); however, the role of estrogen in CHF is not known. We …

Gender differences in cardiac remodeling secondary to chronic volume overload

JD Gardner, GL Brower, JS Janicki - Journal of cardiac failure, 2002 - Elsevier
Background: Gender differences in the prevalence of cardiovascular disease, both clinical
and experimental, led us to evaluate the influence of gender on ventricular remodeling …

[HTML][HTML] Bcl-2 is a key factor for cardiac fibroblast resistance to programmed cell death

M Mayorga, N Bahi, M Ballester, JX Comella… - Journal of Biological …, 2004 - ASBMB
Cardiac fibroblasts play an essential role in the physiology of the heart. These produce
extracellular matrix proteins and synthesize angiogenic and cardioprotective factors …

Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice

Z Chen, CC Chua, YS Ho… - American Journal of …, 2001 - journals.physiology.org
To test whether the antiapoptotic protein Bcl-2 prevents apoptosis and injury of
cardiomyocytes after ischemia-reperfusion (I/R), we generated a line of transgenic mice that …

Is apoptosis present in progression to chronic hypertensive heart failure?

T Tamura, S Said, W Lu, J Harris, D Neufeld… - Journal of Cardiac …, 2000 - Elsevier
BACKGROUND:: Cardiomyocyte apoptosis is believed to occur in hypertension. Isolated
myocyte data from spontaneously hypertensive heart failure (SHHF) rats, however, suggest …

Apoptosis and autophagy contribute to gender difference in cardiac ischemia–reperfusion induced injury in rats

C Chen, LX Hu, T Dong, GQ Wang, LH Wang, XP Zhou… - Life sciences, 2013 - Elsevier
Aims Gender difference in cardiac ischemia–reperfusion (IR) induced injury has been
reported in animal models. However, a large-scale clinical trial found an increase in …

Myocyte death in the failing human heart is gender dependent

S Guerra, A Leri, X Wang, N Finato, C Di Loreto… - Circulation …, 1999 - Am Heart Assoc
Cardiovascular disease is delayed and less common in women than in men. Myocyte death
occurs in heart failure, but only apoptosis has been documented; the role of myocyte …

Gender mediated cardiac protection from adverse ventricular remodeling is abolished by ovariectomy

GL Brower, JD Gardner, JS Janicki - Molecular and cellular biochemistry, 2003 - Springer
Gender differences in the prevalence of cardiovascular disease have been observed both
clinically and experimentally. These cardioprotective effects have frequently been attributed …

[HTML][HTML] Chronic treatment with Carvedilol improves ventricular function and reducesmyocyte apoptosis in an animal model of heart failure

CC Okafor, C Perreault-Micale, RJ Hajjar, D Lebeche… - BMC physiology, 2003 - Springer
Background β-blocker treatmenthas emerged as an effective treatment modality for heart
failure. Interestingly, β-blockers can activate both pro-apoptotic and anti-apoptoticpathways …

Apoptosis in the left ventricle of chronic volume overload causes endocardial endothelial dysfunction in rats

MJ Cox, HS Sood, MJ Hunt… - American Journal …, 2002 - journals.physiology.org
The hypothesis is that chronic increases in left ventricular (LV) load induce oxidative stress
and latent matrix metalloproteinase (MMP) is activated, allowing the heart to dilate in the …